CIK 0001817229 · <br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Sci Off & Head Tech Ops gave up 876 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,061 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Sci Off & Head Tech Ops gave up 1,947 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 5,273 shares (to pay taxes)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,227 shares at $1.42 ($3,162)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,554 shares at $1.37 ($3,499)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 1,033 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,787 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,180 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 3,248 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 1,163 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,353 shares (to pay taxes)
Page 4 of 11 · 212 filings